Congenica
Congenica
About Us
Patient Advocacy and Engagement
Careers
Our offering
Our Platform
Specialist applications
Clinical interpretation services
Customer support
Future developments
Case studies
Investors
Resource library
Recent posts
Events
Webinars
Publications
Get in touch
Please select your location and reference genome:
<
Americas - GRCh37
Americas - GRCh38
Europe, Middle East, Africa - GRCh37
Europe, Middle East, Africa - GRCh38
Recent Posts
All
News
Blog
News
,
Investor
Posted 1st March 2021
Congenica Appoints Kamraan Shariff as Chief Business Development Officer
Read More
News
,
Blog
,
Product
Posted 24th February 2021
Achieving the highest diagnostic yield possible with phenotype-based prioritization of variants
Read More
News
,
Investor
Posted 18th February 2021
David Atkins joins the National Genomics Board as BIA representative
Read More
News
,
Investor
Posted 3rd February 2021
Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology
Read More
News
Posted 27th January 2021
Congenica Contributes to Key Priority within UK Rare Disease Framework
Read More
News
,
Blog
Posted 14th January 2021
Congenica Launches Patient Advocacy and Engagement Advisory Board
Read More
News
,
Investor
Posted 12th January 2021
Congenica Local Cloud Solution to Enable High-quality, Scalable Genomic Analysis in China
Read More
News
,
Blog
,
Product
,
COVID
Posted 14th December 2020
2020 – The Year of Healthcare Heroes and International Teamwork
Read More
News
,
Blog
,
Product
Posted 9th December 2020
Congenica v3.0 - Overcoming Challenges to Accelerate Variant Classification
Read More
News
,
Blog
Posted 7th December 2020
Inclusion in AJHG “Year in Review” 2020
Read More
News
,
Investor
Posted 1st December 2020
Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer
Read More
previous
1
2
3
4
5
...
9
next
News
,
Investor
Posted 1st March 2021
Congenica Appoints Kamraan Shariff as Chief Business Development Officer
Read More
News
,
Blog
,
Product
Posted February Feb 24th 2021
Achieving the highest diagnostic yield possible with phenotype-based prioritization of variants
Read More
News
,
Investor
Posted February Feb 18th 2021
David Atkins joins the National Genomics Board as BIA representative
Read More
News
,
Investor
Posted February Feb 3rd 2021
Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology
Read More
News
Posted January Jan 27th 2021
Congenica Contributes to Key Priority within UK Rare Disease Framework
Read More
News
,
Blog
Posted January Jan 14th 2021
Congenica Launches Patient Advocacy and Engagement Advisory Board
Read More
News
,
Investor
Posted January Jan 12th 2021
Congenica Local Cloud Solution to Enable High-quality, Scalable Genomic Analysis in China
Read More
News
,
Blog
,
Product
,
COVID
Posted December Dec 14th 2020
2020 – The Year of Healthcare Heroes and International Teamwork
Read More
News
,
Blog
,
Product
Posted December Dec 9th 2020
Congenica v3.0 - Overcoming Challenges to Accelerate Variant Classification
Read More
News
,
Blog
Posted December Dec 7th 2020
Inclusion in AJHG “Year in Review” 2020
Read More
News
,
Investor
Posted December Dec 1st 2020
Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer
Read More
previous
1
2
3
4
5
...
9
next
